Johnson & Johnson confirms no asbestos in Johnson's Baby Powder
Tuesday, 3 December 2019 Johnson & Johnson said on Tuesday that more tests showed that Johnson's Baby Powder was free of asbestos after U.S. Food and Drug Administration investigations had found trace amounts of the material.
Johnson & Johnson said recent tests show that Johnson’s Baby Powder was free of asbestos. This comes after the U.S. Food and Drug Administrations found amounts of it in early 2019. A total of 155 tests were conducted by two different third-party labs using four different methods. According to...
Missouri's highest court on Tuesday refused to consider Johnson & Johnson's appeal of a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in its baby powder and other talc products. Bryan Wood reports.
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday. Fred Katayama reports.
Americans need to be prepared for the possibility that they may feel a little unwell. After you get a coronavirus vaccine, if one is authorized, you may experience some negative side effects. The CDC met to discuss whether to recommend the use of any Covid-19 vaccines. The US Food and Drug Administration or FDA is the agency that might authorize one. Volunteers in vaccine trials have reported they frequently feel flu-like effects after getting vaccinated.
On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%
There are currently two COVID-19 vaccines promising results from their Phase 3 trials. Moderna announced that its vaccine was 94.5% effective. Pfizer/BioNTech announced that their vaccine was 95% effective. How long will it take for all Americans to be vaccinated? If the FDA approves the vaccine, Business Insider says first responders and vulnerable populations will receive vaccines through March.
The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Johnson & Johnson (JNJ) is the #14 analyst pick. Johnson..
Credit: Market News Video Duration: 01:02Published